title: Treatment of hypernephroma with xenogeneic immune RNA.
abstract: The treatment of patients with hypernephroma with xenogeneic immune RNA was discussed. The toxicity from xenogeneic immune RNA therapy was minimal in patients receiving simple doses from 4 to 64 mg intracutaneously and with cumulative doses of 450 mg during a 30-month period.
mesh_terms: D000230:Adenocarcinoma / Q000188:drug therapy* / Q000276:immunology; D006801:Humans; D007109:Immunity; D007680:Kidney Neoplasms / Q000188:drug therapy* / Q000276:immunology; D012313:RNA / Q000276:immunology / Q000627:therapeutic use* / Q000633:toxicity
chemical_list: D012313:RNA